HUP0101914A3 - Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph - Google Patents

Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Info

Publication number
HUP0101914A3
HUP0101914A3 HU0101914A HUP0101914A HUP0101914A3 HU P0101914 A3 HUP0101914 A3 HU P0101914A3 HU 0101914 A HU0101914 A HU 0101914A HU P0101914 A HUP0101914 A HU P0101914A HU P0101914 A3 HUP0101914 A3 HU P0101914A3
Authority
HU
Hungary
Prior art keywords
carnitine
nadh
nadph
alkanoyl
composition
Prior art date
Application number
HU0101914A
Other languages
English (en)
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of HUP0101914A2 publication Critical patent/HUP0101914A2/hu
Publication of HUP0101914A3 publication Critical patent/HUP0101914A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0101914A 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph HUP0101914A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000238A IT1299161B1 (it) 1998-04-17 1998-04-17 Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
PCT/IT1999/000088 WO1999053921A1 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Publications (2)

Publication Number Publication Date
HUP0101914A2 HUP0101914A2 (hu) 2002-03-28
HUP0101914A3 true HUP0101914A3 (en) 2002-12-28

Family

ID=11405812

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101914A HUP0101914A3 (en) 1998-04-17 1999-04-14 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph

Country Status (17)

Country Link
EP (1) EP1071424A1 (hu)
JP (1) JP2002512191A (hu)
KR (1) KR20010042765A (hu)
CN (1) CN1299283A (hu)
AU (1) AU750645B2 (hu)
BR (1) BR9909712A (hu)
CA (1) CA2328331A1 (hu)
EE (1) EE200000601A (hu)
HU (1) HUP0101914A3 (hu)
IL (1) IL139014A0 (hu)
IS (1) IS5663A (hu)
IT (1) IT1299161B1 (hu)
NO (1) NO20005128L (hu)
PL (1) PL343482A1 (hu)
SK (1) SK15442000A3 (hu)
TR (1) TR200002894T2 (hu)
WO (1) WO1999053921A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252309B2 (en) 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
DE10326822A1 (de) * 2003-06-11 2005-01-05 Herzpharma Vita-Check Diagnosegeräte GmbH Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels
MX2009012042A (es) * 2007-05-11 2009-12-01 Sigma Tau Ind Farmaceuti Gel util para el suministro de ingredientes activos cosmeticos.
WO2011022786A1 (en) * 2009-08-31 2011-03-03 Pharmaqest Pty Ltd Methods for diagnosis and treatment of chronic fatigue syndrome
CN104306390A (zh) * 2014-10-23 2015-01-28 苏州人本药业有限公司 还原型辅酶ⅱ的用途
CN104840479A (zh) * 2015-02-17 2015-08-19 苏州人本药业有限公司 Nadph在制备治疗心脏疾病药物中的应用
ES2786774B2 (es) * 2017-12-22 2022-03-04 Bontac Bio Eng Shenzhen Co Ltd Composición para compuesto de coenzima NADH, preparación y aplicación del mismo.
PL3755160T3 (pl) 2018-04-20 2022-02-14 Pacotrade Ag Urządzenie do rozdrabniania głęboko mrożonych środków spożywczych przygotowanych w formie bloku
CN109170907A (zh) * 2018-08-30 2019-01-11 泓博元生命科技（深圳）有限公司 一种含有nmn的组合物、应用及运动饮料的制备方法
CN109105702A (zh) * 2018-08-30 2019-01-01 泓博元生命科技（深圳）有限公司 一种含有nadh的组合物、应用及能量补充剂的制备方法
CA3115743A1 (en) * 2018-10-10 2020-04-16 So Ngor Sally LEUNG Health-care product composition for enriching asthenic disease, preparation method therefor and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054698A (hu) * 1964-12-04
US5292538A (en) * 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
DE4335454A1 (de) * 1993-10-19 1995-04-20 Schleicher Peter Geriatrikum
JPH09110708A (ja) * 1995-08-11 1997-04-28 Taisho Pharmaceut Co Ltd 滋養強壮用生薬配合製剤
JPH0959161A (ja) * 1995-08-23 1997-03-04 Taisho Pharmaceut Co Ltd 疲労改善用組成物
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1283951B1 (it) * 1996-03-15 1998-05-07 Mendes Srl Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
US6077828A (en) * 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH10175856A (ja) * 1996-10-14 1998-06-30 Taisho Pharmaceut Co Ltd 疲労改善剤

Also Published As

Publication number Publication date
EE200000601A (et) 2002-04-15
IS5663A (is) 2000-10-13
CA2328331A1 (en) 1999-10-28
KR20010042765A (ko) 2001-05-25
TR200002894T2 (tr) 2001-01-22
WO1999053921A1 (en) 1999-10-28
NO20005128L (no) 2000-12-18
SK15442000A3 (sk) 2001-06-11
IT1299161B1 (it) 2000-02-29
BR9909712A (pt) 2000-12-26
NO20005128D0 (no) 2000-10-12
JP2002512191A (ja) 2002-04-23
IL139014A0 (en) 2001-11-25
HUP0101914A2 (hu) 2002-03-28
ITRM980238A1 (it) 1999-10-17
ITRM980238A0 (it) 1998-04-17
PL343482A1 (en) 2001-08-27
AU750645B2 (en) 2002-07-25
CN1299283A (zh) 2001-06-13
AU3442899A (en) 1999-11-08
EP1071424A1 (en) 2001-01-31

Similar Documents

Publication Publication Date Title
HU9903361D0 (en) Filter-device with collecting-vessel and with heating-device
HK1024498A1 (en) Adhesive composition and adhesive sheet
SG85628A1 (en) Compound and its use
AU2052800A (en) Metal and wood bat
IL183948A0 (en) Conjugates of peg-urate oxidase and use thereof
GB9813271D0 (en) Composition and use
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
HU9900536D0 (en) Mg alloy member and its use
PL347357A1 (en) Novel composition and use
ZA985096B (en) Composition compound and use
AU1037900A (en) Magnetic bearing and its use
SG87813A1 (en) Curable epoxide composition and its use
HUP0103845A2 (hu) Fertőtlenítő készítmény és alkalmazása
AU9293998A (en) Wrinkle and malodour reducing composition
HUP0101914A3 (en) Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
EP1056455A4 (en) EPIMORPHIN COMPOUND AND USE OF THE SAME
AU9301998A (en) Composition and methods using galectin-1
GB9803232D0 (en) Compound composition and use
EP1090935A4 (en) FLUOROCOPOLYMER AND COMPOSITION THEREOF
HUP0101602A3 (en) Fertility improving composition and application thereof
IL120481A0 (en) Combined enzyme composition and its use
SG77680A1 (en) An epoxy-resin composition and use thereof
GB9722392D0 (en) Composition and use
EP1066051A4 (en) SCIELLIN AND ITS USE